Cervical Human Papillomavirus in transplanted Italian women: A long-term prospective follow-up study

Journal of Clinical Virology

Volumn 51, Issue 4, 2011, Pages 250-254

  Origoni, Massimo ^a   Stefani, Chiara ^a   Dell'Antonio, Giacomo ^a   Carminati, Guia ^a   Parma, Marta ^a   Candiani, Massimo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cervical intraepithelial neoplasia; CIN; HPV; Human Papillomavirus; Immunosuppression; Transplant

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENITAL TRACT INFECTION; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIROLOGY; WART VIRUS;

EID: 79960039237     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.05.002     Document Type: Article

References (31)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancer in 1985. Int J Cancer 1993, 54:594-606.
2. Lowy D.R., Schiller J.T. Prophylactic human papillomavirus vaccines. J Clin Invest 2006, 116:1167-1173.
3. Schmiedeskamp M.R., Kockler D.R. Human papillomavirus vaccines. Ann Pharmacother 2006, 40:1344-1352.
4. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Klummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
5. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002, 347:1645-1651.
6. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus type 16 and 18 in young women: a randomised controlled trial. Lancet 2004, 364:1757-1765.
7. Schiller J.T., Davies P. Delivering on the promise: HPV vaccines and cervical cancer. Nat Rev Microbiol 2004, 2:343-347.
8. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102(Suppl. 5A):3-8.
9. Schiffman M.H. Recent progress in defining the epidemiology of human papillomavirus infection and cervival neoplasia. J Natl Cancer Inst 1992, 84:394-398.
10. Lowy D.R., Kirnbauer R., Schiller J.T. Genital human papillomavirus infection. Proc Natl Acad Sci USA 1994, 91:2436-2440.
11. Zaki S.R., Judd R., Coffield L.M., Greer P., Rolston F., Evatt B.L. Human papillomavirus infection and anal carcinoma Retrospective analysis by in situ hybridisation and the polymerase chain reaction. Am J Pathol 1992, 140:1345-1355.
12. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87:796-802.
13. Meisels A. Cytological diagnosis of human papillomavirus. Influence of age and pregnancy stage. Acta Cytol 1992, 36:480-482.
14. Barber H., Incidence Prevalence, and median survival rates of gynaecological cancer 1982, John Wright-PSG, Boston.
15. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423-428.
16. Halpert R., Fruchter R.G., Sedlis A., Butt K, Boyce J.G., Sillman F.H. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986, 68:251-258.
17. Alloub M.I., Barr B.B., McLaren K.M.M., Smith I.W., Bunney M.H., Smart G.E. Human papillomavirus infections and cervical intraepithelial neoplasia in women with renal allografts. Br Med J 1989, 298:153-156.
18. Ogunbiyi O.A., Scholefield J.H., Raftery A.T., Smith J.H., Duffy S., Sharp F., et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994, 81:365-367.
19. Palefsky J.M. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1992, 8:283-295.
20. Wright T.C., Ellerbrock T.V., Chiasson M.A., Van Devanter N., Sun X.W. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994, 84:591-597.
21. Six C., Heard I., Bergeron C., Orth G., Poveda J.D., Zagury P., et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions among HIV-positive and negative women. AIDS 1998, 12:1047-1056.
22. Lacey H.B., Wilson G.E., Tilston P., Wilkins E.G., Bailey A.S., Corbitt G., et al. A study of anal intraepithelial neoplasia I HIV-positive homosexual men. Sex Transm Infect 1999, 75:172-177.
23. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997, 337:1343-1358.
24. Johnson L.C., Burnett A.F., Willet G.D., Young M.A., Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992, 79:321-327.
25. Maiman M., Fruchter R.S., Guy L., Cuthill S., Levine P., Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993, 71:402-406.
26. Vernon S.D., Reeves W.C., Clancy K.A., Laga M., St Louis M., Gary H.E., et al. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type-1 seropositive and seronegative women. J Infect Dis 1994, 169:1108-1112.
27. Rodi J, Vasile C, Verderosa E, Giarin F, Signorelli A, Barbagin M, et al. Organizzazione ed analisi quinquennale di una banca dati di Pap Test eseguiti su un campione di popolazione generale: confronto con altri dati di riferimento. Progetto Percorso Donna Update 2001 - Online Congress Padova, Italy. http://www.cyber-medica.org/.
28. Fairley C.K., Chen S., Tabrizi S.N., McNeil J., Becker G., Walzer R., et al. Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol Dial Transplant 1994, 9:416-420.
29. Morrison E.A., Dole P., Sun X.W., Stern L., Wright T.C. Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients. Nephrol Dial Transplant 1996, 11:1603-1606.
30. Schneider V., Kay S., Lee H.M. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983, 27:220-224.
31. Gentile G., Formelli G., Orsoni G., Rinaldi A.M., Busacchi P. Immunosuppression and human genital papillomavirus infection. Eur J Gynaec Oncol 1991, 12(1):79-81.